How large is the ventral hernia treatment market, and what is its growth trajectory?
The ventral hernia treatment market size has grown strongly in recent years. It will grow from $4.87 billion in 2024 to $5.23 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing prevalence of obesity, increasing awareness about ventral hernias, growing aging population, rising disposable income, increasing demand for minimally invasive surgical procedures.
The ventral hernia treatment market size is expected to see strong growth in the next few years. It will grow to $6.90 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to rising demand for outpatient procedures, rising spend on healthcare, increasing government initiatives, rising demand for hernia repair surgeries, increasing investment in research and development. Major trends in the forecast period include advanced hernia repair devices, bioabsorbable materials, strategic collaboration, robotic-assisted surgery devices, remote monitoring.
Get Your Free Sample of The Global Ventral Hernia Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21315&type=smp
What are the key forces behind the ventral hernia treatment market’s growth in recent years?
Increasing prevalence of obesity is expected to propel the growth of the ventral hernia treatment market going forward. Obesity is a medical condition characterized by an excessive amount of body fat that significantly impacts an individual’s health. Increasing prevalence of obesity is due to poor diet, sedentary lifestyle, genetic factors, lack of physical activity, environmental influences, and emotional stress. Ventral hernia treatment supports obesity patients by addressing the complications that arise from excessive weight, as it helps alleviate strain on the abdominal wall, reduces the risk of hernia recurrence, and enhances overall abdominal strength, which is essential for promoting mobility and encouraging healthier lifestyle choices in individuals struggling with obesity. For instance, in March 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported that approximately one in eight people worldwide were struggling with obesity. This included 2.5 billion adults (aged 18 years and older) who were overweight, with 890 million of them living with obesity. Among adults, 43% were overweight, and 16% were classified as obese. Additionally, the number of overweight children under the age of 5 reached 37 million. Therefore, increasing prevalence of obesity drives the ventral hernia treatment market.
What are the major segments of the ventral hernia treatment market?
The ventral hernia treatment market covered in this report is segmented –
1) By Type: Epigastric (Stomach Area) Hernia, Umbilical (Belly Button) Hernia, Incisional Hernia
2) By Diagnosis: Ultrasound, Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI)
3) By Surgery: Open Hernia Surgery, Laparoscopic Surgery, Robotic Hernia Surgery
4) By End Users: Hospitals, Ambulatory Surgical Centres, Clinics
Subsegments:
1) By Epigastric (Stomach Area) Hernia: Small Epigastric Hernia, Large Epigastric Hernia
2) By Umbilical (Belly Button) Hernia: Congenital Umbilical Hernia, Acquired Umbilical Hernia
3) By Incisional Hernia: Primary Incisional Hernia, Recurrent Incisional Hernia
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/ventral-hernia-treatment-global-market-report
Which companies dominate the ventral hernia treatment market?
Major companies operating in the ventral hernia treatment market are Johnson And Johnson Services Inc., AbbVie, Abbott Laboratories, Medtronic Plc, Becton, Dickinson and Company (BD), Baxter International Inc., Braun Melsungen AG, Zimmer Biomet, Olympus Corporation, W.L. Gore and Associates Inc, STERIS Plc, Cook Medical Inc., KARL STORZ, Cooper University Health Care, Mölnlycke Health Care, Integra LifeSciences Holdings, ConMed Corporation, Aesculap Inc, Richard Wolf GmbH, Ethicon Inc, Tela Bio, Microline Surgical, Hernia Mesh S.R.L., Insightra Medical Inc, Advanced MedTech Solutions Pvt Ltd.
What major trends will shape the ventral hernia treatment market during the forecast period?
Major companies operating in the ventral hernia treatment market are focusing on technological advancements, such as laparoscopic and open hernia mesh fixation devices, to improve surgical outcomes, reduce complications, and enhance patient recovery. Laparoscopic and open hernia mesh fixation devices refer to medical tools used to secure mesh during hernia repair surgeries, either through minimally invasive (laparoscopic) or traditional open surgical approaches. For instance, in March 2024, TELA Bio Inc., a US-based medical technology company, launched the LIQUIFIX FIX8 laparoscopic and LIQUIFIX precision open hernia mesh fixation devices in the U.S. LIQUIFIX FIX8 is for minimally invasive repairs, while LIQUIFIX precision is for open femoral and inguinal hernia repairs. These FDA-approved devices use liquid anchors to affix mesh without penetrating tissue, reducing trauma and complications. With over 1.2 million hernia procedures annually in the U.S., LIQUIFIX offers precision and safety in sensitive areas and minimizes vascular or nerve injury risks.
What are the key regional dynamics of the ventral hernia treatment market, and which region leads in market share?
North America was the largest region in the ventral hernia treatment market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the ventral hernia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Ventral Hernia Treatment Market Report 2025 Offer?
The ventral hernia treatment market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Ventral hernia treatment refers to the medical procedures and interventions used to repair hernias that occur in the abdominal wall. It typically involves the use of robotic-assisted surgery, tension-free mesh repair, and laparoscopic intraperitoneal. The treatment aims to reposition displaced tissues, strengthen the abdominal wall, and prevent recurrence. These treatments are used to relieve pain, restore normal function, and reduce the risk of complications such as bowel obstruction or strangulation.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21315
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
